Multiple Myeloma Treatment in India – VRd, ASCT & Daratumumab
Multiple myeloma treatment in India from $10,000. Bortezomib-lenalidomide-dexamethasone (VRd), autologous stem-cell transplant, and daratumumab at expert haematology centres.
Multiple myeloma treatment in India from $10,000. Bortezomib-lenalidomide-dexamethasone (VRd), autologous stem-cell transplant, and daratumumab at expert haematology centres.